Showing results (61-70 of 72) with videos related to
Sort By:
Pageof 8
British Journal of Haematology|July 9, 2016
Detection of prognostic factors in children and adolescents with Burkitt and Diffuse Large B-Cell Lymphoma treated with the AIEOP LNH-97 protocolMarta Pillon, Lara Mussolin, Elisa Carraro, et al.Hemasphere|March 3, 2021
Droplet Digital PCR Improves IG-/TR-based MRD Risk Definition in Childhood B-cell Precursor Acute Lymphoblastic LeukemiaIrene Della Starza, Vittorio Nunes, Federica Lovisa, et al.Diagnostics (Basel, Switzerland)|September 28, 2021
Prognostic Role of Minimal Disseminated Disease and NOTCH1/FBXW7 Mutational Status in Children with Lymphoblastic Lymphoma: The AIEOP ExperienceFederica Lovisa, Ilaria Gallingani, Elena Varotto, et al.Journal of the National Cancer Institute|February 5, 2014
Crizotinib in advanced, chemoresistant anaplastic lymphoma kinase-positive lymphoma patientsCarlo Gambacorti Passerini, Francesca Farina, Alessandra Stasia, et al.Pediatric Blood & Cancer|March 11, 2015
Long-term results of the AIEOP LNH-97 protocol for childhood lymphoblastic lymphomaMarta Pillon, Maurizio Aricò, Lara Mussolin, et al.The Lancet. Haematology|April 24, 2023
Effect of rituximab on immune status in children with mature B-cell non-Hodgkin lymphoma: a prespecified secondary analysis of the Inter-B-NHL Ritux 2010 trialSarah Alexander, Anne Aupérin, Simon Bomken, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges AheadVéronique Minard-Colin, Laurence Brugières, Alfred Reiter, et al.Leukemia|October 18, 2024
Single-cell transcriptomics of pediatric Burkitt lymphoma reveals intra-tumor heterogeneity and markers of therapy resistanceClarissa Corinaldesi, Antony B Holmes, Gaia Martire, et al.Pediatric Blood & Cancer|June 3, 2022
Brentuximab vedotin in the treatment of paediatric patients with relapsed or refractory Hodgkin's lymphoma: Results of a real-life studyDavide Massano, Elisa Carraro, Lara Mussolin, et al.British Journal of Cancer|October 31, 2024
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphomaMatteo Villa, Geeta G Sharma, Federica Malighetti, et al.Pageof 8